Controlled trial of ketorolac in tension-type headache

R. Norman Harden, David Rogers, Kathleen Fink, Richard H. Gracely

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

Intramuscular ketorolac 60 mg, meperidine 50 mg plus promethazine 25 mg, and normal saline were compared in acute exacerbations of tension-type headache. Forty-one subjects (30 females and 11 males) were randomized into three groups and evaluated by the McGill Short-Form Pain Questionnaire before treatment, and 0.5, 1, 2, 3, 4, 5, and 6 hours after treatment. All three groups showed a significant treatment effect that persisted for the 6 hours of evaluation. Ketorolac treatment was significantly better than placebo at 0.5 and 1 hour by the Visual Analog Scale (VAS) and Pain Rating Index, and better than meperidine at 2 hours (by the VAS). Meperidine and placebo did not differ at any time point. Ketorolac is effective in short-term treatment of tension-type headache.

Original languageEnglish (US)
Pages (from-to)507-509
Number of pages3
JournalNeurology
Volume50
Issue number2
DOIs
StatePublished - Jan 1 1998

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Controlled trial of ketorolac in tension-type headache'. Together they form a unique fingerprint.

Cite this